Veritas Asset Management LLP trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,078,201 shares of the healthcare conglomerate's stock after selling 803,870 shares during the quarter. UnitedHealth Group makes up approximately 8.1% of Veritas Asset Management LLP's holdings, making the stock its 5th largest position. Veritas Asset Management LLP owned 0.12% of UnitedHealth Group worth $448,133,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $25,000. Anfield Capital Management LLC raised its stake in UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after acquiring an additional 55 shares during the period. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Nalls Sherbakoff Group LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $27,000. Finally, Lifetime Wealth Management P.C. acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $29,000. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Trading Down 0.1%
Shares of NYSE:UNH opened at $401.52 on Monday. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market cap of $360.40 billion, a P/E ratio of 25.84, a P/E/G ratio of 1.40 and a beta of 0.62. The company has a 50 day moving average of $415.74 and a 200-day moving average of $352.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analysts' expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm's quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is currently 59.72%.
Analyst Ratings Changes
UNH has been the topic of a number of recent research reports. Argus upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $400.00 target price on the stock in a research note on Wednesday, April 22nd. Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a report on Thursday, July 16th. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $466.00 to $516.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. Finally, Weiss Ratings lowered UnitedHealth Group from a "hold (c)" rating to a "hold (c-)" rating in a report on Tuesday, July 28th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $455.92.
Read Our Latest Stock Report on UNH
Insider Buying and Selling
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 500 shares of the business's stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total value of $205,000.00. Following the sale, the chief executive officer directly owned 16,497 shares in the company, valued at approximately $6,763,770. The trade was a 2.94% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.19% of the company's stock.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.